AAAAAA

   
Results: 1-25 |
Results: 25
PACLITAXEL AND CARBOPLATIN IN COMBINATION WITH GEMCITABINE (PCG) - A PHASE I-II TRIAL IN NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: FAVARETTO A PACCAGNELLA A TUMOLO S BARBIERI F CERESOLI G GULISANO M ONIGA F BEARZ A FIORENTINO MV
Citation: A. Favaretto et al., PACLITAXEL AND CARBOPLATIN IN COMBINATION WITH GEMCITABINE (PCG) - A PHASE I-II TRIAL IN NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 438-438
CLINICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS OF OLIGODENDROGLIOMA
Authors: BRANDES AA FIORENTINO MV
Citation: Aa. Brandes et Mv. Fiorentino, CLINICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS OF OLIGODENDROGLIOMA, Cancer treatment reviews, 24(2), 1998, pp. 101-111
UNUSUAL NASAL AND ORBITAL INVOLVEMENT OF GLIOBLASTOMA-MULTIFORME - A CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: BRANDES A CAROLLO C GARDIMAN M SCELZI E BOTTIN R ZAMPIERI P RIGON A FIORENTINO MV
Citation: A. Brandes et al., UNUSUAL NASAL AND ORBITAL INVOLVEMENT OF GLIOBLASTOMA-MULTIFORME - A CASE-REPORT AND REVIEW OF THE LITERATURE, Journal of neuro-oncology, 36(2), 1998, pp. 179-183
TREATMENT OF HIGH-GRADE GLIOMAS IN THE ELDERLY
Authors: BRANDES A FIORENTINO MV
Citation: A. Brandes et Mv. Fiorentino, TREATMENT OF HIGH-GRADE GLIOMAS IN THE ELDERLY, Oncology, 55(1), 1998, pp. 1-6
CARBOPLATIN AND TENIPOSIDE CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME - A PHASE-II STUDY
Authors: BRANDES AA RIGON A ZAMPIERI P ERMANI M CAROLLO C ALTAVILLA G TURAZZI S CHIERICHETTI F FIORENTINO MV
Citation: Aa. Brandes et al., CARBOPLATIN AND TENIPOSIDE CONCURRENT WITH RADIOTHERAPY IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME - A PHASE-II STUDY, Cancer, 82(2), 1998, pp. 355-361
TAXOL AND FLUOROURACIL AS 2ND LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
Authors: FORNASIERO A GHIOTTO C DANIELE O DAMANZO P AVERSA SML SILENI VC FIORENTINO MV
Citation: A. Fornasiero et al., TAXOL AND FLUOROURACIL AS 2ND LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Breast, 6(5), 1997, pp. 917-917
INCIDENCE AND RISK OF THROMBOEMBOLISM DURING TREATMENT OF HIGH-GRADE GLIOMAS - A PROSPECTIVE-STUDY
Authors: BRANDES AA SCELZI E SALMISTRARO G ERMANI M CAROLLO C BERTI F ZAMPIERI P BAIOCCHI C FIORENTINO MV
Citation: Aa. Brandes et al., INCIDENCE AND RISK OF THROMBOEMBOLISM DURING TREATMENT OF HIGH-GRADE GLIOMAS - A PROSPECTIVE-STUDY, European journal of cancer, 33(10), 1997, pp. 1592-1596
SURGICAL 2ND LOOK IN OVARIAN-CANCER - A RANDOMIZED STUDY IN PATIENTS WITH LAPAROSCOPIC COMPLETE REMISSION - A NORTHEASTERN ONCOLOGY COOPERATIVE GROUP OVARIAN-CANCER COOPERATIVE GROUP-STUDY
Authors: NICOLETTO MO TUMOLO S TALAMINI R SALVAGNO L FRANCESCHI S VISONA E MARIN G ANGELINI F BRIGATO G SCARABELLI C CARBONE A CECCHETTO A PROSPERI A ROSABIAN A GIUSTO M CIMA GP MORASSUT S NASCIMBEN O VINANTE O FIORENTINO MV
Citation: Mo. Nicoletto et al., SURGICAL 2ND LOOK IN OVARIAN-CANCER - A RANDOMIZED STUDY IN PATIENTS WITH LAPAROSCOPIC COMPLETE REMISSION - A NORTHEASTERN ONCOLOGY COOPERATIVE GROUP OVARIAN-CANCER COOPERATIVE GROUP-STUDY, Journal of clinical oncology, 15(3), 1997, pp. 994-999
PHASE-II TRIAL WITH BCNU PLUS ALPHA-INTERFERON IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
Authors: BRANDES AA SCELZI E ZAMPIERI P RIGON A ROTILIO A AMISTA P BERTI F FIORENTINO MV
Citation: Aa. Brandes et al., PHASE-II TRIAL WITH BCNU PLUS ALPHA-INTERFERON IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS, American journal of clinical oncology, 20(4), 1997, pp. 364-367
PREOPERATIVE CHEMORADIOTHERAPY IN NONSMALL CELL LUNG-CANCER STAGE-IIIPATIENTS - FEASIBILITY, TOXICITY AND LONG-TERM RESULTS OF A PHASE-II STUDY
Authors: FAVARETTO A PACCAGNELLA A TOMIO L SARTORI F CIPRIANI A ZUIN R REFFOSCO L CALABRO F REA F GHIOTTO C CHIARIONSILENI V ONIGA F LOREGGIAN L FIORENTINO MV
Citation: A. Favaretto et al., PREOPERATIVE CHEMORADIOTHERAPY IN NONSMALL CELL LUNG-CANCER STAGE-IIIPATIENTS - FEASIBILITY, TOXICITY AND LONG-TERM RESULTS OF A PHASE-II STUDY, European journal of cancer, 32A(12), 1996, pp. 2064-2069
THE ROLE OF CHEMOTHERAPY IN RECURRENT MALIGNANT GLIOMAS - AN OVERVIEW
Authors: BRANDES AA FIORENTINO MV
Citation: Aa. Brandes et Mv. Fiorentino, THE ROLE OF CHEMOTHERAPY IN RECURRENT MALIGNANT GLIOMAS - AN OVERVIEW, Cancer investigation, 14(6), 1996, pp. 551-558
EARLY CHEMOTHERAPY AND CONCURRENT RADIOCHEMOTHERAPY IN HIGH-GRADE GLIOMA
Authors: BRANDES AA RIGON A ZAMPIERI P SCELZI E AMISTA P BERTI F ROTILIO A GARDIMAN M FIORENTINO MV
Citation: Aa. Brandes et al., EARLY CHEMOTHERAPY AND CONCURRENT RADIOCHEMOTHERAPY IN HIGH-GRADE GLIOMA, Journal of neuro-oncology, 30(3), 1996, pp. 247-255
MITOMYCIN-C, VINBLASTINE, AND CARBOPLATIN REGIMEN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL
Authors: PACCAGNELLA A FAVARETTO A ONIGA F FESTI G LAURO S MORABITO A OSSANA L SARTORE F DEPOLI F FIORENTINO MV
Citation: A. Paccagnella et al., MITOMYCIN-C, VINBLASTINE, AND CARBOPLATIN REGIMEN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL, Cancer, 78(8), 1996, pp. 1701-1707
GONADAL ATROPHY AS A CAUSE OF THYMIC HYPERPLASIA AFTER CHEMOTHERAPY
Authors: SPERANDIO P TOMIO P OLIVER RTD FIORENTINO MV PAGANO F
Citation: P. Sperandio et al., GONADAL ATROPHY AS A CAUSE OF THYMIC HYPERPLASIA AFTER CHEMOTHERAPY, British Journal of Cancer, 74(6), 1996, pp. 991-992
TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC) IN ELDERLY PATIENTS (EP)
Authors: PACCAGNELLA A FAVARETTO A TOMIO L MORABITO A ONIGA F DEPOLI F SARTORE F FIORENTINO MV
Citation: A. Paccagnella et al., TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC) IN ELDERLY PATIENTS (EP), European journal of cancer, 31A, 1995, pp. 82-82
PRELIMINARY-RESULTS OF A PROSPECTIVE EVALUATION OF H-3 THYMIDINE LABELING INDEX IN GLIOMAS
Authors: FIORENTINO MV BRANDES A ZAMPIERI P DITTADI R GARDIMAN M SALBE C PISTORELLO M ALESSIO L GION M SCELZI E
Citation: Mv. Fiorentino et al., PRELIMINARY-RESULTS OF A PROSPECTIVE EVALUATION OF H-3 THYMIDINE LABELING INDEX IN GLIOMAS, European journal of cancer, 31A, 1995, pp. 272-272
PSYCHOLOGICAL ANALYSIS OF GLIOMA PATIENTS UNDERGOING COMBINED CHEMORADIOTHERAPY - AN INTERIM-REPORT
Authors: CAPOVILLA ED MARIGGIO AL BRANDES A ZAMPIERI P RIGON A SCELZI WE FIORENTINO MV
Citation: Ed. Capovilla et al., PSYCHOLOGICAL ANALYSIS OF GLIOMA PATIENTS UNDERGOING COMBINED CHEMORADIOTHERAPY - AN INTERIM-REPORT, European journal of cancer, 31A, 1995, pp. 292-292
HYBRID MOPP ABVD AND RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE
Authors: SALVAGNO L SORARU M SOTTI G AVERSA S SILENI VC MAZZAROTTO R SCARZELLO G BIANCO A PAPPAGALLO GL FIORENTINO MV
Citation: L. Salvagno et al., HYBRID MOPP ABVD AND RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(2), 1995, pp. 173-179
CONTINUOUS MITOXANTRONE INFUSION IN PRETREATED EPITHELIAL OVARIAN-CANCER
Authors: NICOLETTO MO PADRINI R KOUSSIS H ROSABIAN A AVERSA S ENDRIZZI L AZZONI P PALUMBO M FIORENTINO MV
Citation: Mo. Nicoletto et al., CONTINUOUS MITOXANTRONE INFUSION IN PRETREATED EPITHELIAL OVARIAN-CANCER, Cancer chemotherapy and pharmacology, 35(6), 1995, pp. 506-510
PHASE-III TRIAL OF INITIAL CHEMOTHERAPY IN STAGE-III OR STAGE-IV HEADAND NECK CANCERS - A STUDY BY THE RUPPO-DI-STUDIO-SUI-TUMORI-DELLA-TESTA-E-DEL-COLLO
Authors: PACCAGNELLA A ORLANDO A MARCHIORI C ZORAT PL CAVANIGLIA G SILENI VC JIRILLO A TOMIO L FILA G FEDE A ENDRIZZI L BARI M SAMPOGNARO E BALLI M GAVA A PAPPAGALLO GL FIORENTINO MV
Citation: A. Paccagnella et al., PHASE-III TRIAL OF INITIAL CHEMOTHERAPY IN STAGE-III OR STAGE-IV HEADAND NECK CANCERS - A STUDY BY THE RUPPO-DI-STUDIO-SUI-TUMORI-DELLA-TESTA-E-DEL-COLLO, Journal of the National Cancer Institute, 86(4), 1994, pp. 265-272
THE PSYCHO-ONCOLOGY SERVICE IN PADOVA - OUR EXPERIENCE OVER THE LAST DECADE
Authors: FIORENTINO MV MARTELLA S CAPOVILLA ED MARIGGIO A
Citation: Mv. Fiorentino et al., THE PSYCHO-ONCOLOGY SERVICE IN PADOVA - OUR EXPERIENCE OVER THE LAST DECADE, Psycho-oncology, 3(3), 1994, pp. 239-240
TRENDS FOR PSYCHO-ONCOLOGY IN ITALY - A PRELIMINARY SURVEY OF THE OPERATING STRUCTURES
Authors: CAPOVILLA ED FIORENTINO MV MARTELLA S MARIGGIO A
Citation: Ed. Capovilla et al., TRENDS FOR PSYCHO-ONCOLOGY IN ITALY - A PRELIMINARY SURVEY OF THE OPERATING STRUCTURES, Psycho-oncology, 3(3), 1994, pp. 245-247
PROLONGED SURVIVAL (17 YEARS) IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AFTER THERAPY FOR HODGKINS-DISEASE
Authors: SALVAGNO L SORARU M LESZL A KOUSSIS H DEFRANCHIS G FIORENTINO MV
Citation: L. Salvagno et al., PROLONGED SURVIVAL (17 YEARS) IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AFTER THERAPY FOR HODGKINS-DISEASE, Leukemia & lymphoma, 16(1-2), 1994, pp. 177-181
LATE RELAPSES IN HODGKINS-DISEASE - OUTCOME OF PATIENTS RELAPSING MORE THAN 12 MONTHS AFTER PRIMARY CHEMOTHERAPY
Authors: SALVAGNO L SORARU M AVERSA SML BIANCO A SILENI VC PAPPAGALLO GL FIORENTINO MV
Citation: L. Salvagno et al., LATE RELAPSES IN HODGKINS-DISEASE - OUTCOME OF PATIENTS RELAPSING MORE THAN 12 MONTHS AFTER PRIMARY CHEMOTHERAPY, Annals of oncology, 4(8), 1993, pp. 657-662
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INCREASES DOSE INTENSITY OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - RELATIONSHIP BETWEEN CLINICAL-RESULTS, PERIPHERAL-BLOOD CELL MODIFICATIONS, AND BONE-MARROWKINETICS
Authors: PACCAGNELLA A FAVARETTO A RICCARDI A DANOVA M GHIOTTO C GIORDANO M PAPPAGALLO G COMIS S PANOZZO M CHIECOBIANCHI L FIORENTINO MV
Citation: A. Paccagnella et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INCREASES DOSE INTENSITY OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - RELATIONSHIP BETWEEN CLINICAL-RESULTS, PERIPHERAL-BLOOD CELL MODIFICATIONS, AND BONE-MARROWKINETICS, Cancer, 72(3), 1993, pp. 697-706
Risultati: 1-25 |